Regulatory/EMA/FDA/PMDA Archives

Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment

The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public worksho

Tucson, AZ — January 22, 2018 — Critical Path Institute (C-Path) announced today that the European Medicines Agency (E

Tucson, AZ – December 18, 2017 Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

November 22, 2017

December 1, 2017

January 1, 2017

November 1, 2016 US Food and Drug Administration Awards Critical Path Institute Three Grants, One Contract TUCSON, A

Oct 17, 2016 IMI SAFE-T and C-Path PSTC Obtain Regulatory Support for New Liver Safety Biomarkers US FDA and EMA Let

December 10, 2016

October 12, 2016 College Park Marriott Hotel and Conference Center, Hyattsville, Maryland SPONSORED BY: Critical Path Institute &n